$UNM

Argenx SE Expands VYVGART’s Market Presence with Strategic Growth

$UNM Argenx SE (NASDAQ: ARGX), a leading biotechnology company, continues to advance its flagship autoimmune treatment, VYVGART. The company’s latest…